Published Date: 27 May 2025
Moving beyond traditional methods of observing thinly sliced and stained cancer tissues, a collaborative international research team led by KAIST has successfully developed a new technology. This innovation uses advanced ...
Read Full NewsA dose-dense modified Stanford V regimen may improve early complete responses and allow some pediatric patients with low-risk Hodgkin lymphoma to skip radiotherapy.
In a small phase II study of patients with KRAS G12C-mutated NSCLC, poor performance status, not advanced age, was associated with reduced treatment response.
1.
AI tool automates liver tumor detection and monitoring
2.
Exercise can counter detrimental effects of cancer treatment, review suggests
3.
Could semaglutide be used to treat addiction in addition to obesity?
4.
Active Surveillance Lawsuits; More Eligibility for Studies; Biosimilars Make News.
5.
Chicken Broth Recall; Medicaid at Risk; Princess Kate Thanks Medical Staff
1.
The Predictive Power of Theranostics in Palliative Neuroendocrine Tumor Management
2.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
3.
Understanding Lymphedema: Symptoms, Causes, and Treatment
4.
The Ins and Outs of Glossectomy: What You Need to Know
5.
Understanding Protein C Deficiency: Symptoms, Causes, and Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
2.
Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation